Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Role of Growth Hormone Antagonism in Modulating Insulin Sensitivity in Subjects With Insulin Resistance But Without Diabetes

NCT02023918 is registered in ClinicalTrials.gov with University of California, San Francisco as lead sponsor.

NCT NCT02023918
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02023918 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Role of Growth Hormone Antagonism in Modulating Insulin Sensitivity in Subjects With Insulin Resistance But Without Diabetes
Lead sponsor
University of California, San Francisco
Phase
Phase 2
Overall status
Completed
Start date
January 31, 2014
Completion date
December 31, 2015
Enrollment
6 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes, insulin resistance, metabolic syndrome